< Back to situations

Get alerts on this situation

We’ll email you as it develops, and you can follow the whole thread from day one.

Unsubscribe anytime.

[SITUATION] · [ACTIVE]

2 clusters · 16 sources · 3 days · First seen 3 days ago · Last updated 1 day ago

Categories: BUSINESS

Core Scientific AI‑colocation expansion

Entities: Core Laboratories · Civeo Corporation · Chris Hill · Larry Bruno · Stonegate Capital Partners

Overview

Core Scientific reported second‑quarter 2026 revenue of $164.2 million, more than double the $78.6 million earned a year earlier. The surge was driven by AI and high‑performance computing colocation services, which generated $136.7 million and now account for roughly 83 % of total sales. Despite the revenue growth, the company posted a net loss of $1.15 billion, a non‑cash charge linked to the revaluation of outstanding warrants and contingent‑value rights as its share price rose.

The firm now leases about 1.1 GW of customer power capacity, a portfolio that could deliver over $24 billion in contracted revenue over the life of the contracts. It also announced a strategic 15‑year partnership with Advanced Micro Devices (AMD) covering roughly 530 MW of AI‑ready data‑center capacity, with the potential to expand to 2.5 GW and generate more than $14 billion in base revenue.

Core Scientific’s Bitcoin treasury was rebuilt to roughly 848 BTC (about $54 million) after adding 301 BTC during the quarter. Emerging from Chapter 11 bankruptcy in early 2024, the company continues its transition from Bitcoin mining to providing AI infrastructure services.

Claims

What the coverage asserts, and how well corroborated each claim is across sources.

[● 3 SOURCES] Civeo Corporation reported second‑quarter 2026 revenue of $180.0 million. (Civeo Q2 earnings release)
[● 3 SOURCES] Adjusted EBITDA for the quarter was $23.8 million. (Civeo Q2 earnings release)
[● 3 SOURCES] Operating cash flow turned positive at $11.6 million. (Civeo Q2 earnings release)
[○ 1 SOURCE] Core Laboratories reported Q2 2026 revenue of $124.6 million, up more than 2% from the prior quarter and down 4% year over year. (Core Laboratories Q2 Earnings Call Highlights)
[○ 1 SOURCE] Core Laboratories' service revenue for Q2 2026 was $94.3 million, flat sequentially and down 2% year over year. (Core Laboratories Q2 Earnings Call Highlights)
[○ 1 SOURCE] Castle Biosciences reported Q2 2026 revenue of $99.86 million, a 20.1% increase year over year. (Castle Biosciences (NASDAQ:CSTL) Sees Strong Trading Volume After Earnings Beat)
[○ 1 SOURCE] Castle Biosciences posted an adjusted loss per share of $0.07 for Q2 2026, better than the consensus estimate of $0.44 loss per share. (Castle Biosciences (NASDAQ:CSTL) Sees Strong Trading Volume After Earnings Beat)
[○ 1 SOURCE] Castle Biosciences raised its full‑year 2026 revenue outlook to $365‑$375 million. (Castle Biosciences (NASDAQ:CSTL) Sees Strong Trading Volume After Earnings Beat)

Timeline

1 day ago

[BUSINESS] 7 sources
CareDx Raises Full-Year Revenue Forecast to $500M After Strong Q2 Results
CareDx Q2 revenue jumped 52% to $132 M, net income rose to $20 M, and the firm raised its full‑year revenue target to $490‑$500 M after CMS coverage affirmation and the Naveris acquisition.
3 days ago

[BUSINESS] 10 sources
Core Scientific AI‑colocation revenue doubles to $164 m as net loss hits $1.15 bn
Core Scientific’s Q2 revenue jumped to $164 m on AI colocation growth, now 83 % of sales, while a $1.15 bn non‑cash loss hit earnings. The firm announced an AMD partnership and holds about 848 BTC.

Sources

aijourn.com · bitcoinmagazine.com · blockonomi.com · citybizlist.com · coingeek.com · cointelegraph.com · criptotendencias.com · cryptobriefing.com · mommygearest.com · news.alphastreet.com · otravel.com · seekingalpha.com · spacemoney.com.br · stocknews.com · stocktitan.net · time.news